Cargando…
Expert opinion on translational research for advanced glioblastoma treatment
Malignant gliomas are known to be one of the most difficult diseases to diagnose and treat because of the infiltrative growth pattern, rapid progression, and poor prognosis. Many antitumor drugs are not ideal for the treatment of gliomas due to the blood-brain barrier. Temozolomide (TMZ) is a DNA al...
Autores principales: | Cui, Xiaoteng, Wang, Yunfei, Zhou, Junhu, Wang, Qixue, Kang, Chunsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Compuscript
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10246444/ https://www.ncbi.nlm.nih.gov/pubmed/37092846 http://dx.doi.org/10.20892/j.issn.2095-3941.2023.0012 |
Ejemplares similares
-
Single-Cell Transcriptomics of Glioblastoma Reveals a Unique Tumor Microenvironment and Potential Immunotherapeutic Target Against Tumor-Associated Macrophage
por: Cui, Xiaoteng, et al.
Publicado: (2021) -
Editorial: The State-of-Art in Immuno-Oncology, What to Do With Glioblastoma?
por: Cui, Xiaoteng, et al.
Publicado: (2021) -
Identification of the E2F1-RAD51AP1 axis as a key factor in MGMT-methylated GBM TMZ resistance
por: Zhou, Junhu, et al.
Publicado: (2023) -
Rapid design and development of CRISPR-Cas13a targeting SARS-CoV-2 spike protein
por: Wang, Lin, et al.
Publicado: (2021) -
Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma
por: Cui, Xiaoteng, et al.
Publicado: (2023)